|4Jan 14, 5:25 PM ET

Borges David J. 4

4 · OMEROS CORP · Filed Jan 14, 2026

Insider Transaction Report

Form 4
Period: 2026-01-12
Borges David J.
VP, Finance & CAO
Transactions
  • Sale

    Common stock

    [F1]
    2026-01-12$12.72/sh30,000$381,6000 total
  • Exercise/Conversion

    Common stock

    2026-01-13$3.06/sh+30,000$91,80030,000 total
  • Sale

    Common stock

    [F2]
    2026-01-13$12.31/sh30,000$369,3150 total
  • Exercise/Conversion

    Stock Option (right to buy)

    [F3]
    2026-01-1330,00065,000 total
    Exercise: $3.06Exp: 2034-04-25Common Stock (30,000 underlying)
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $12.56 to $13.06. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
  • [F2]This transaction was executed in multiple trades at prices ranging from $12.13 to $12.62. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
  • [F3]This option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2024. Installments vest and become exercisable on each monthly anniversary thereafter.
Signature
/s/ Peter B. Cancelmo, Attorney-in-Fact|2026-01-14

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    D. BORGES FORM 4